Tramadol Hydrochloride Tablets (盐酸曲马多片)盐酸曲马多片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

曲马多是一种在国家药监局注册认定的药品。该药品含有曲马多-a5e86a7f等成分。

该药品关联的活性成分包括:曲马多tramadol。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:北京华素制药股份有限公司Chinese legal name: 北京华素制药股份有限公司。

您可以探索含有相同成分的其他药品:曲马多-a5e86a7f成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

tramadol is a medicine registered with the national drug regulatory authority. It contains tramadol as active ingredient(s).

Active ingredients associated with this product: tramadoltramadol.

Manufacturers recorded for this product: 北京华素制药股份有限公司Chinese legal name: 北京华素制药股份有限公司.

Explore other medicines containing the same ingredient: tramadol products.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 盐酸曲马多片Tramadol Hydrochloride Tablets (盐酸曲马多片)
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 50mg50 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 北京华素制药股份有限公司Chinese legal name: 北京华素制药股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H10960043

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H10960043

Manufacturer

Chinese legal name: 北京华素制药股份有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H10960043

生产企业

北京华素制药股份有限公司(国产)

适应症

主要用于癌症疼痛,骨折或术后疼痛等各种急、慢性疼痛。

用法用量

口服。一次50~100mg,必要时可重复。日剂量不超过400mg。

不良反应

偶见出汗、恶心、呕吐、纳差、头晕、无力、思睡等。罕见皮疹、心悸、体位性低血压,在病人疲劳时更易产生。

禁忌

酒精、安眠药、镇痛剂或其他精神药物中毒者禁用。

注意事项

1.功能不全者、心脏疾患者酌情减量使用或慎用。|2.不得与单胺氧化酶抑制剂同用。|3.与中枢安静剂(如安定等)合用时需减量。|4.长期使用不能排除产生耐药性或药物依赖性的可能。但不能作为对阿片类有依赖性病人的代用品,因不能抑制吗啡的戒断症状。|5.有药物滥用或依赖性倾向的病人只能短期使用。

贮藏

密封保存。

规格

50mg

证据Evidence

  • 批准文号: 国药准字H10960043
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.